0001193805-19-000017.txt : 20190102
0001193805-19-000017.hdr.sgml : 20190102
20190102181234
ACCESSION NUMBER: 0001193805-19-000017
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190101
FILED AS OF DATE: 20190102
DATE AS OF CHANGE: 20190102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SASSINE ANDY
CENTRAL INDEX KEY: 0001515322
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35932
FILM NUMBER: 19503023
MAIL ADDRESS:
STREET 1: 82 DEVONSHIRE STREET
CITY: BOSTON
STATE: MA
ZIP: 02109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arcturus Therapeutics Ltd.
CENTRAL INDEX KEY: 0001566049
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10628 SCIENCE CENTER DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-900-2660
MAIL ADDRESS:
STREET 1: 10628 SCIENCE CENTER DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: ALCOBRA LTD.
DATE OF NAME CHANGE: 20130104
3
1
e618126_3-sassine.xml
X0206
3
2019-01-01
0
0001566049
Arcturus Therapeutics Ltd.
ARCT
0001515322
SASSINE ANDY
C/O ARCTURUS THERAPEUTICS LTD.
10628 SCIENCE CENTER DRIVE, SUITE 250
SAN DIEGO
CA
92121
1
1
0
0
Chief Financial Officer
Ordinary Shares
237596
D
STOCK OPTION (right to purchase)
8.00
2028-08-23
Ordinary Shares
3750
D
STOCK OPTION (right to purchase)
8.00
2028-08-23
Ordinary Shares
10000
D
STOCK OPTION (right to purchase)
8.00
2018-08-24
2028-08-23
Ordinary Shares
2500
D
STOCK OPTION (right to purchase)
8.00
2028-08-23
Ordinary Shares
20000
D
STOCK OPTION (right to purchase)
4.53
2028-12-31
Ordinary Shares
100000
D
The Reporting Person is filing this form in connection with the Issuer's transition from reporting as a foreign private issuer to reporting as a domestic issuer, effective January 1, 2019.
Fully vested as of December 31, 2018.
Vesting monthly over a one year period from August 24, 2018.
Options to purchase 25,000 shares vest one year from the date of grant and the remainder vests in equal monthly installments over the three year period thereafter.
/s/ Andy Sassine
2019-01-02